These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21903246)

  • 1. The regulation of MASPIN expression in epithelial ovarian cancer: association with p53 status, and MASPIN promoter methylation: a gynecologic oncology group study.
    Alvarez Secord A; Darcy KM; Hutson A; Huang Z; Lee PS; Jewell EL; Havrilesky LJ; Markman M; Muggia F; Murphy SK
    Gynecol Oncol; 2011 Nov; 123(2):314-9. PubMed ID: 21903246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic regulation of maspin expression in human ovarian carcinoma cells.
    Rose SL; Fitzgerald MP; White NO; Hitchler MJ; Futscher BW; De Geest K; Domann FE
    Gynecol Oncol; 2006 Aug; 102(2):319-24. PubMed ID: 16457875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant methylation of RASSF2A in tumors and plasma of patients with epithelial ovarian cancer.
    Wu Y; Zhang X; Lin L; Ma XP; Ma YC; Liu PS
    Asian Pac J Cancer Prev; 2014; 15(3):1171-6. PubMed ID: 24606436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter hypermethylation influences the suppressive role of maternally expressed 3, a long non-coding RNA, in the development of epithelial ovarian cancer.
    Sheng X; Li J; Yang L; Chen Z; Zhao Q; Tan L; Zhou Y; Li J
    Oncol Rep; 2014 Jul; 32(1):277-85. PubMed ID: 24859196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer.
    Zhang W; Barger CJ; Link PA; Mhawech-Fauceglia P; Miller A; Akers SN; Odunsi K; Karpf AR
    Epigenetics; 2015; 10(8):736-48. PubMed ID: 26098711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of cell-type-specific methylation at the Maspin gene promoter is frequently involved in undifferentiated thyroid cancers.
    Ogasawara S; Maesawa C; Yamamoto M; Akiyama Y; Wada K; Fujisawa K; Higuchi T; Tomisawa Y; Sato N; Endo S; Saito K; Masuda T
    Oncogene; 2004 Feb; 23(5):1117-24. PubMed ID: 14743202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MnSOD up-regulates maspin tumor suppressor gene expression in human breast and prostate cancer cells.
    Duan H; Zhang HJ; Yang JQ; Oberley LW; Futscher BW; Domann FE
    Antioxid Redox Signal; 2003 Oct; 5(5):677-88. PubMed ID: 14580325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutant p53 and aberrant cytosine methylation cooperate to silence gene expression.
    Oshiro MM; Watts GS; Wozniak RJ; Junk DJ; Munoz-Rodriguez JL; Domann FE; Futscher BW
    Oncogene; 2003 Jun; 22(23):3624-34. PubMed ID: 12789271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation in the p53 promoter in epithelial ovarian cancer.
    Chmelarova M; Krepinska E; Spacek J; Laco J; Beranek M; Palicka V
    Clin Transl Oncol; 2013 Feb; 15(2):160-3. PubMed ID: 22855178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [E-cadherin promoter methylation and demethylation in epithelial ovarian carcinoma cells].
    Qu PP; Shi Z; Li N
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):538-41. PubMed ID: 19957556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of maspin expression is associated with development and progression of gastric carcinoma with p53 abnormality.
    Ito R; Nakayama H; Yoshida K; Oda N; Yasui W
    Oncol Rep; 2004 Nov; 12(5):985-90. PubMed ID: 15492782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The regulation mechanism of MASPIN expression in ovarian carcinoma].
    Ma Y; Peng ZL; Chen X; Li X; Yan JF
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Jan; 44(1):15-20. PubMed ID: 23600201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing of the maspin gene by promoter hypermethylation in thyroid cancer.
    Boltze C; Schneider-Stock R; Quednow C; Hinze R; Mawrin C; Hribaschek A; Roessner A; Hoang-Vu C
    Int J Mol Med; 2003 Oct; 12(4):479-84. PubMed ID: 12964023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tumour suppressor SOX11 is associated with improved survival among high grade epithelial ovarian cancers and is regulated by reversible promoter methylation.
    Sernbo S; Gustavsson E; Brennan DJ; Gallagher WM; Rexhepaj E; Rydnert F; Jirström K; Borrebaeck CA; Ek S
    BMC Cancer; 2011 Sep; 11():405. PubMed ID: 21943380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TAp63gamma can substitute for p53 in inducing expression of the maspin tumor suppressor.
    Spiesbach K; Tannapfel A; Mössner J; Engeland K
    Int J Cancer; 2005 Apr; 114(4):555-62. PubMed ID: 15578720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of demethylating agent 5-aza-2(')-deoxycytidine and histone deacetylase inhibitor FR901228 on maspin gene expression in oral cancer cell lines.
    Murakami J; Asaumi J; Maki Y; Tsujigiwa H; Kuroda M; Nagai N; Yanagi Y; Inoue T; Kawasaki S; Tanaka N; Matsubara N; Kishi K
    Oral Oncol; 2004 Jul; 40(6):597-603. PubMed ID: 15063388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic silencing of maspin gene expression in human breast cancers.
    Domann FE; Rice JC; Hendrix MJ; Futscher BW
    Int J Cancer; 2000 Mar; 85(6):805-10. PubMed ID: 10709100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FBXW7 is involved in the acquisition of the malignant phenotype in epithelial ovarian tumors.
    Kitade S; Onoyama I; Kobayashi H; Yagi H; Yoshida S; Kato M; Tsunematsu R; Asanoma K; Sonoda K; Wake N; Hata K; Nakayama KI; Kato K
    Cancer Sci; 2016 Oct; 107(10):1399-1405. PubMed ID: 27486687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation-induced silencing of maspin contributes to the proliferation of human glioma cells.
    Xu L; Liu H; Yu J; Wang Z; Zhu Q; Li Z; Zhong Q; Zhang S; Qu M; Lan Q
    Oncol Rep; 2016 Jul; 36(1):57-64. PubMed ID: 27177016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant expression of the maspin gene associated with epigenetic modification in melanoma cells.
    Wada K; Maesawa C; Akasaka T; Masuda T
    J Invest Dermatol; 2004 Mar; 122(3):805-11. PubMed ID: 15086568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.